• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Global Injectable Drug Delivery Devices Market Report 2021: Comparative Analysis of Products at Various Stages of Development and Information on Clinical Trials

Share:

August 16, 2021

The “Injectable Drug Delivery Devices Landscape, 2021” report has been added to ResearchAndMarkets.com’s offering.

“Injectable Drug Delivery Devices Pipeline Product Landscape, 2021” provides comprehensive information about the Injectable Drug Delivery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Injectable Drug Delivery Devices are defined as the administration of a drug into a patient’s blood through a delivery device.

Scope

  • Extensive coverage of the Injectable Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of Injectable Drug Delivery Devices and lists all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
  • Identify and understand important and diverse types of Injectable Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Read more here

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Finance.Yahoo

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Cimarron Healthcare Capital Announces Acquisition of Ascent Behavioral HealthCimarron Healthcare Capital Announces Acquisition of Ascent Behavioral Health
  • AI-powered COVID-19 Solution Reduces Report Turnaround Times By 30%, Study FindsAI-powered COVID-19 Solution Reduces Report Turnaround Times By 30%, Study Finds
  • Femtech Market has Potential But Struggles to Score Investor DollarsFemtech Market has Potential But Struggles to Score Investor Dollars
  • Cohere Health, Humana Expand Partnership to Transform Prior Authorization ProcessCohere Health, Humana Expand Partnership to Transform Prior Authorization Process
  • Amazon Confirms Nationwide Expansion of Telehealth ServicesAmazon Confirms Nationwide Expansion of Telehealth Services
  • BetterLife CEO Discusses Merger, Planned Interferon Treatment Trials and Potential Subsequent FDA Emergency Use AuthorizationBetterLife CEO Discusses Merger, Planned Interferon Treatment Trials and Potential Subsequent FDA Emergency Use Authorization
  • Strategic Partnership in Singapore Looks Set to Address the Worsening Myopia Situation in AsiaStrategic Partnership in Singapore Looks Set to Address the Worsening Myopia Situation in Asia
  • Zogenix Buys Modis In $400 Million-Plus Deal To Make Larger Rare Disease CompanyZogenix Buys Modis In $400 Million-Plus Deal To Make Larger Rare Disease Company

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications